Globus Medical Inc
NYSE:GMED
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
49.79
85.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Globus Medical Inc
Wall Street
Price Targets
GMED Price Targets Summary
Globus Medical Inc
According to Wall Street analysts, the average 1-year price target for
GMED
is 97.37 USD
with a low forecast of 80.8 USD and a high forecast of 120.75 USD.
GMED Last Price Targets
Globus Medical Inc
The latest public price target was made on Aug 28, 2024 by
Ryan Zimmerman
from
BTIG
,
who expects
GMED
stock to
drop by 8%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Ryan Zimmerman
BTIG
|
77
USD
Downside 8% |
3 months ago
Aug 28, 2024
|
Globus Medical price target raised to $77 from $75 at BTIG
TheFly
|
Vik Chopra
Wells Fargo
|
78
USD
Downside 7% |
4 months ago
Aug 7, 2024
|
Wells Fargo Upgrades Globus Medical (GMED) to Overweight
StreetInsider
|
Drew Ranieri
Morgan Stanley
|
71
USD
Downside 15% |
5 months ago
Jul 15, 2024
|
Globus Medical price target raised to $71 from $67 at Morgan Stanley
TheFly
|
|
Ryan Zimmerman
BTIG
|
72
USD
Downside 14% |
6 months ago
May 29, 2024
|
Globus Medical (GMED) PT Raised to $72 at BTIG
StreetInsider
|
Matt O'Brien
Piper Sandler
|
80
USD
Downside 4% |
7 months ago
May 20, 2024
|
Globus Medical upgraded to Overweight from Neutral at Piper Sandler
TheFly
|
|
Ryan Zimmerman
BTIG
|
60
USD
Downside 28% |
9 months ago
Mar 18, 2024
|
BTIG Upgrades Globus Medical (GMED) to Buy
StreetInsider
|
Mathew Blackman
Stifel Nicolaus
|
61
USD
Downside 27% |
1 year ago
Sep 19, 2023
|
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GMED's stock price target?
Price Target
97.37
USD
According to Wall Street analysts, the average 1-year price target for
GMED
is 97.37 USD
with a low forecast of 80.8 USD and a high forecast of 120.75 USD.
What is Globus Medical Inc's Revenue forecast?
Projected CAGR
19%
For the last 8 years the
compound annual growth rate for
Globus Medical Inc's revenue is
14%.
The projected
CAGR
for the next 4 years is
19%.
What is Globus Medical Inc's Operating Income forecast?
Projected CAGR
40%
For the last 8 years the
compound annual growth rate for
Globus Medical Inc's operating income is
3%.
The projected
CAGR
for the next 4 years is
40%.
What is Globus Medical Inc's Net Income forecast?
Projected CAGR
50%
For the last 8 years the
compound annual growth rate for
Globus Medical Inc's net income is
1%.
The projected
CAGR
for the next 4 years is
50%.
You don't have any saved screeners yet
